Literature DB >> 9820357

Risk factors and clinical impact of central line infections in the surgical intensive care unit.

C Charalambous1, S M Swoboda, J Dick, T Perl, P A Lipsett.   

Abstract

OBJECTIVE: To determine the risk factors and clinical impact of central line infections in critically ill surgical patients.
DESIGN: Retrospective study.
SETTING: The surgical intensive care unit of a large tertiary care university hospital. PATIENTS: A total of 232 consecutive central line catheters sent for culture from patients in a surgical intensive care unit during 1996 and 1997. Catheters were sent for microbiologic analysis when the patient was clinically infected and the central line was a possible source.
INTERVENTIONS: None. MAIN OUTCOME MEASURES: Risk factors associated and clinical impact of a positive catheter culture.
RESULTS: Of 232 consecutive catheters from 93 patients sent for microbiologic analysis, 114 catheters (49%) had no growth, 40 (17%) were colonized (<15 colonies), and 78 (34%) were considered infected (> or =15 colonies). Univariate analysis showed that site (internal jugular vs subclavian, P<.001), catheter use (monitoring > dialysis > fluid > nutrition, P=.006), placement in the operating room vs the intensive care unit (P=.02), and placement of a new catheter (> guide wire, > new site, P=.003) were all significant factors. Surprisingly, neither the number of lunmens nor the duration of the catheter in situ were predictors when a catheter was suspected and not proved infected compared with a suspected and proved catheter infection. In the multiple regression model, the placement of the catheter in the internal jugular position was the single most important predictor of a catheter infection (P<.001; odds ratio, 1.83; 95% confidence interval [CI], 1.41-2.37). The presence or absence of a specific clinical sign of infection was not predictive of a proved catheter infection. Eighty-six percent of patients had gram-positive bacteria identified on the culture, while the remaining patients had gram-negative bacteria or Candida identified. Of the catheter infections, 68% were monomicrobial, whereas 32% were polymicrobial. Of the catheters sent for microbiologic analysis, 209 (90%) had concurrent peripheral blood cultures for analysis. Nineteen (32%) with no growth from the catheter, and 14 (23%) of colonized catheters had concurrent bacteremia; all had another identifiable cause of infection. Twenty-seven (45%) of infected catheters had a concurrent bacteremia, and 9 of 27 had a second site positive for the same organism. Death related to the infection occurred in 15 patients, 2 in the first 72 hours and 13 in the following 14 days.
CONCLUSIONS: Central line infections remain an important cause of morbidity and mortality. Comprehensive review of hospital practices may show a directed focus for performance improvement practices. At our institution, internal jugular catheters have the highest rate of infection. This may suggest breaks in technique during catheter insertion or during catheter maintenance and care.

Entities:  

Mesh:

Year:  1998        PMID: 9820357     DOI: 10.1001/archsurg.133.11.1241

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  12 in total

1.  Characterization of bacterial isolates collected from a sheep model of osseointegration.

Authors:  Dustin L Williams; Roy D Bloebaum; James P Beck; Cathy A Petti
Journal:  Curr Microbiol       Date:  2010-05-11       Impact factor: 2.188

2.  The risk of catheter-related bloodstream infection after withdrawal of colonized catheters is low.

Authors:  M Guembe; M Rodríguez-Créixems; P Martín-Rabadán; L Alcalá; P Muñoz; E Bouza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-10-31       Impact factor: 3.267

3.  Enhancing the fever workup utilizing a multi-technique modeling approach to diagnose infections more accurately.

Authors:  Adam M A Fadlalla; Joseph F Golob; Jeffrey A Claridge
Journal:  Surg Infect (Larchmt)       Date:  2010-07-28       Impact factor: 2.150

4.  Catheter-related infection in gastrointestinal fistula patients.

Authors:  Ge-Fei Wang; Jian-An Ren; Jun Jiang; Cao-Gan Fan; Xin-Bo Wang; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

5.  Risk factors and prognosis of catheter-related bloodstream infection in critically ill patients: a multicenter study.

Authors:  Jose Garnacho-Montero; Teresa Aldabó-Pallás; Mercedes Palomar-Martínez; Jordi Vallés; Benito Almirante; Rafael Garcés; Fabrio Grill; Miquel Pujol; Cristina Arenas-Giménez; Eduard Mesalles; Ana Escoresca-Ortega; Marina de Cueto; Carlos Ortiz-Leyba
Journal:  Intensive Care Med       Date:  2008-07-12       Impact factor: 17.440

6.  More interventions do not necessarily improve outcome in critically ill patients.

Authors:  Philipp G H Metnitz; Ana Reiter; Barbara Jordan; Thomas Lang
Journal:  Intensive Care Med       Date:  2004-02-26       Impact factor: 17.440

7.  The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters.

Authors:  Nasia Safdar; Dennis G Maki
Journal:  Intensive Care Med       Date:  2003-11-26       Impact factor: 17.440

8.  Central venous catheter-related bloodstream infections in the intensive care unit.

Authors:  Harsha V Patil; Virendra C Patil; M N Ramteerthkar; R D Kulkarni
Journal:  Indian J Crit Care Med       Date:  2011-10

9.  Ventilator associated pneumonia: comparison between quantitative and qualitative cultures of tracheal aspirates.

Authors:  Luis Fernando Aranha Camargo; Fernando Vinícius De Marco; Carmen Sílvia Valente Barbas; Cristiane Hoelz; Marco Aurélio Scarpinella Bueno; Milton Rodrigues; Verônica Moreira Amado; Raquel Caserta; Marinês Dalla Valle Martino; Jacyr Pasternak; Elias Knobel
Journal:  Crit Care       Date:  2004-10-14       Impact factor: 9.097

Review 10.  Systematic review of the safety and efficacy of contrast injection via venous catheters for contrast-enhanced computed tomography.

Authors:  S B Buijs; M W Barentsz; M L J Smits; J W C Gratama; P E Spronk
Journal:  Eur J Radiol Open       Date:  2017-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.